Market Price

718.50 

-11.50 -1.6%

as of Sep 26 '22

52 Week Range:

566.00 921.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '18 Dec '19 Dec '20 Dec '21
Earnings BIT 33.00
27.00
41.00
40.00
77.63
56.86
79.68
136.96
growth rate -18.2% 51.9% -2.4% 94.1% -26.8% 40.1% 71.9%
Avg.PE 26.20
35.48
38.91
growth rate 35.4% 2.3%
Balance Sheet Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 60.00
67.00
77.00
130.00
163.00
227.37
258.28
309.39
328.40
growth rate 11.7% 14.9% 68.8% 25.4% 39.5% 13.6% 19.8% 6.1%
Acct.Payable 41.00
31.00
44.00
65.00
55.00
69.34
78.92
68.96
119.93
growth rate -24.4% 41.9% 47.7% -15.4% 26.1% 13.8% -12.6% 73.9%
Cur.Assets 259.00
297.00
273.00
462.00
468.00
533.87
589.99
651.00
826.17
growth rate 14.7% -8.1% 69.2% 1.3% 14.1% 10.5% 10.3% 26.9%
Total Assets 477.00
538.00
630.00
1,004.00
1,021.00
1,103.11
1,168.71
1,242.28
1,669.16
growth rate 12.8% 17.1% 59.4% 1.7% 8.0% 6.0% 6.3% 34.4%
Cash 73.00
127.00
50.00
47.00
32.00
39.88
25.44
54.41
72.62
growth rate 74.0% -60.6% -6.0% -31.9% 24.6% -36.2% 113.9% 33.5%
Inventory 122.00
99.00
123.00
257.00
244.00
227.55
256.96
272.43
364.66
growth rate -18.9% 24.2% 108.9% -5.1% -6.7% 12.9% 6.0% 33.9%
Cur.Liabilities 85.00
99.00
107.00
148.00
124.00
151.29
301.53
193.59
270.79
growth rate 16.5% 8.1% 38.3% -16.2% 22.0% 99.3% -35.8% 39.9%
Liabilities 161.00
175.00
247.00
511.00
361.00
424.33
477.03
509.09
980.94
growth rate 8.7% 41.1% 106.9% -29.4% 17.5% 12.4% 6.7% 92.7%
LT Debt 38.00
60.00
113.00
215.00
91.00
110.00
139.97
480.00
growth rate 57.9% 88.3% 90.3% -57.7% 20.9% 12.8% 242.9%
Equity 678.78
691.68
733.18
688.22
growth rate 1.9% 6.0% -6.1%
Common Shares 69.00
8.00
8.00
8.00
8.51
116.26
105.30
93.20
growth rate -88.4% 0.0% 0.0% 6.4% 1,265.5% -9.4% -11.5%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 22.00
48.00
82.00
95.00
65.00
58.78
61.63
68.76
113.10
growth rate 118.2% 70.8% 15.9% -31.6% -9.6% 4.9% 11.6% 64.5%
Cash Dividends 9.96
10.79
11.62
12.63
growth rate 8.3% 7.7% 8.7%
Cash From OA 54.00
68.00
25.00
23.00
57.00
106.00
65.64
114.77
119.75
growth rate 25.9% -63.2% -8.0% 147.8% 86.0% -38.1% 74.8% 4.3%
FCF 32.00
20.00
-57.00
-72.00
-8.00
47.22
4.02
46.01
6.65
growth rate -37.5% -100.0% 0.0% 0.0% 100.0% -91.5% 1,045.5% -85.6%
Income Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '18 Dec '19 Dec '20 Dec '21
Sales 368.00
375.00
315.00
481.00
718.00
794.30
833.51
845.06
1,102.42
growth rate 1.9% -16.0% 52.7% 49.3% 10.6% 4.9% 1.4% 30.5%
Op.Income 21.00
33.00
27.00
41.00
40.00
77.63
56.86
79.68
136.96
growth rate 57.1% -18.2% 51.9% -2.4% 94.1% -26.8% 40.1% 71.9%
IBT 70.16
51.43
74.03
126.53
growth rate -26.7% 43.9% 70.9%
Net Income 21.00
54.00
39.00
39.00
28.00
56.31
53.15
60.87
95.60
growth rate 157.1% -27.8% 0.0% -28.2% 101.1% -5.6% 14.5% 57.1%
Gross Profit 83.00
99.00
73.00
91.00
109.00
156.53
172.72
176.20
239.57
growth rate 19.3% -26.3% 24.7% 19.8% 43.6% 10.4% 2.0% 36.0%
R&D 27.47
33.30
31.20
40.37
growth rate 21.2% -6.3% 29.4%

Quarterly Statements

Item Name Dec '16 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 10.00
19.91
19.91
48.57
48.57
growth rate 99.1% 0.0% 143.9% 0.0%
Balance Sheet Dec '16 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 163.00
244.25
244.25
328.40
328.40
growth rate 49.9% 0.0% 34.5% 0.0%
Acct.Payable 55.00
94.64
94.64
119.93
119.93
growth rate 72.1% 0.0% 26.7% 0.0%
Cur.Assets 468.00
733.79
733.79
826.17
826.17
growth rate 56.8% 0.0% 12.6% 0.0%
Total Assets 1,021.00
1,586.37
1,586.37
1,669.16
1,669.16
growth rate 55.4% 0.0% 5.2% 0.0%
Cash 32.00
59.15
59.15
72.62
72.62
growth rate 84.8% 0.0% 22.8% 0.0%
Inventory 244.00
403.49
403.49
364.66
364.66
growth rate 65.4% 0.0% -9.6% 0.0%
Cur.Liabilities 124.00
273.47
273.47
270.79
270.79
growth rate 120.5% 0.0% -1.0% 0.0%
Liabilities 361.00
793.41
793.41
980.94
980.94
growth rate 119.8% 0.0% 23.6% 0.0%
LT Debt 91.00
260.00
260.00
480.00
480.00
growth rate 185.7% 0.0% 84.6% 0.0%
Equity 792.97
792.97
688.22
688.22
growth rate 0.0% -13.2% 0.0%
Common Shares 8.00
93.20
93.20
93.20
93.20
growth rate 1,065.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '16 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 14.00
31.03
31.03
25.52
25.52
growth rate 121.7% 0.0% -17.8% 0.0%
Cash Dividends 6.32
6.32
6.32
6.32
growth rate 0.0% 0.0% 0.0%
Cash From OA 16.00
48.45
48.45
11.42
11.42
growth rate 202.8% 0.0% -76.4% 0.0%
FCF 2.00
17.42
17.42
-14.10
-14.10
growth rate 771.1% 0.0% -100.0% 0.0%
Income Statement Dec '16 Mar '21 Jun '21 Sep '21 Dec '21
Sales 182.00
233.44
233.44
317.77
317.77
growth rate 28.3% 0.0% 36.1% 0.0%
Op.Income 10.00
19.91
19.91
48.57
48.57
growth rate 99.1% 0.0% 143.9% 0.0%
IBT 19.08
19.08
44.19
44.19
growth rate 0.0% 131.7% 0.0%
Net Income 7.00
14.65
14.65
33.15
33.15
growth rate 109.2% 0.0% 126.4% 0.0%
Gross Profit 26.00
46.16
46.16
73.63
73.63
growth rate 77.5% 0.0% 59.5% 0.0%
R&D 9.65
9.65
10.54
10.54
growth rate 0.0% 9.2% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (24.95)

YOY Growth Grade:

F (10.54)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 51.48 50.67 26.48
EPS / Growth -1.3% 14.18 14.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 2.00 26.65 26.65
Future EPS 15.66 15.66 15.66
Value Price
MOS %
7.74
-98.9%
103.19
-85.6%
103.19
-85.6%
MOS Price 3.87 51.60 51.60
IRT 40.86 40.86 40.86

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.